Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05413018
PHASE2

An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficacy and safety of Oral Azacitidine (CC-486) in Chinese participants with acute myeloid leukemia in complete remission.

Official title: A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Compare Efficacy and Safety of Oral Azacitidine (CC-486) Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Chinese Patients With Acute Myeloid Leukemia in Complete Remission

Key Details

Gender

All

Age Range

55 Years - Any

Study Type

INTERVENTIONAL

Enrollment

34

Start Date

2022-08-19

Completion Date

2026-03-01

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

DRUG

CC-486

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Locations (34)

Local Institution - 0031

Hefei, Anhui, China

Local Institution - 0013

Beijing, BJ, China

Local Institution - 0027

Beijing, BJ, China

Local Institution - 0028

Chongqing, CQ, China

Local Institution - 0003

Guangzhou, GD, China

Local Institution - 0008

Guangzhou, GD, China

Local Institution - 0010

Shenzhen, GD, China

Local Institution - 0002

Shijiazhuang, HE, China

Local Institution - 0022

Xuzhou, Jiangsu, China

Local Institution - 0005

Shenyang, Liaoning, China

Local Institution - 0020

Shenyang, LN, China

Local Institution - 0016

Chengdu, SC, China

Local Institution - 0006

Shanghai, SH, China

Local Institution - 0030

Xi'an, SN, China

Local Institution - 0033

Taiyuan, SX, China

Local Institution - 0001

Tianjin, TJ, China

Local Institution - 0009

Ürümqi, Xinjiang, China

Local Institution - 0007

Wenzhou, ZJ, China

Local Institution - 0017

Changchun, China

Local Institution - 0019

Changsha, China

Local Institution - 0015

Changsha, China

Local Institution - 0035

Ganzhou, China

Local Institution - 0012

Guangzhou, China

Local Institution - 0014

Hangzhou, China

Local Institution - 0032

Harbin, China

Local Institution - 0011

Jinan, China

Local Institution - 0024

Kunming, China

Local Institution - 0026

Lanzhou, China

Local Institution - 0018

Nanchang, China

Local Institution - 0029

Nanjing, China

Local Institution - 0021

Suzhou, China

Local Institution - 0023

Tianjin, China

Local Institution - 0034

Zhangzhou, China

Local Institution - 0004

Zhengzhou, China